Tazi et al., 2018 - Google Patents
Disentangling host-microbiota regulation of lipid secretion by enterocytes: insights from commensals Lactobacillus paracasei and Escherichia coli. mBio 9: e01493-18Tazi et al., 2018
View PDF- Document ID
- 3195701171417401640
- Author
- Tazi A
- Araujo J
- Mulet C
- Arena E
- Nigro G
- Pédron T
- Sansonetti P
- Publication year
- Publication venue
- Pubmed PMC
External Links
Snippet
The gut microbiota contributes to nutrients absorption and metabolism by enterocytes, but the molecular mechanisms involved remain poorly understood, and most conclusions are inferred from studies comparing germfree and conventional animals colonized with diverse …
- 241000588724 Escherichia coli 0 title abstract description 136
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tazi et al. | Disentangling host-microbiota regulation of lipid secretion by enterocytes: insights from commensals Lactobacillus paracasei and Escherichia coli | |
| Judkins et al. | Probiotics, nutrition, and the small intestine | |
| AU2022203731B2 (en) | Use of pasteurized Akkermansia for treating metabolic disorders | |
| CN108367030B (en) | Use of fecal bacillus prodigiosus and Desulfovibrio inerticus for treating or preventing diabetes and intestinal diseases | |
| TWI572354B (en) | Anti-inflammatory composition | |
| Liu et al. | Limosilactobacillus reuteri and caffeoylquinic acid synergistically promote adipose browning and ameliorate obesity-associated disorders | |
| Liang et al. | Lactiplantibacillus plantarum H-87 prevents high-fat diet-induced obesity by regulating bile acid metabolism in C57BL/6J mice | |
| Zhu et al. | Faecal microbiota transplantation‐mediated jejunal microbiota changes halt high‐fat diet‐induced obesity in mice via retarding intestinal fat absorption | |
| Zhu et al. | Cholesterol-lowering effect of bile salt hydrolase from a Lactobacillus johnsonii strain mediated by FXR pathway regulation | |
| Yan et al. | Oryzanol attenuates high fat and cholesterol diet-induced hyperlipidemia by regulating the gut microbiome and amino acid metabolism | |
| Guo et al. | Bile salt hydrolase and S‐layer protein are the key factors affecting the hypocholesterolemic activity of Lactobacillus casei‐fermented milk in hamsters | |
| US20250152637A1 (en) | Akkermansia for preventing and/or treating reward dysregulation disorders | |
| Shao et al. | bsh 1 Gene of Lactobacillus plantarum AR113 Plays an Important Role in Ameliorating Western Diet-Aggravated Colitis | |
| Lun et al. | Chitosan oligosaccharide activates brown adipose tissue by modulating the gut microbiota and bile acid pathways based on faecal microbiota transplantation | |
| Tazi et al. | Disentangling host-microbiota regulation of lipid secretion by enterocytes: insights from commensals Lactobacillus paracasei and Escherichia coli. mBio 9: e01493-18 | |
| WO2021011887A1 (en) | Clostridia consortia compositions and methods of treating obesity, metabolic syndrome and irritable bowel disease | |
| US20250375505A1 (en) | Compositions and methods for modifying bile acids to regulate lipid and steroid metabolism | |
| Tsai et al. | Yeast with bacteriocin from ruminal bacteria enhances glucose utilization, reduces ectopic fat accumulation, and alters cecal microbiota in dietary-induced obese mice | |
| NL2036594B1 (en) | Bacterium comprising phytate-degradation pathway | |
| Boscaini | Novel insights into the mechanisms underlying the anti-obesity effects of whey protein | |
| Ermolenko et al. | Health Reversion Effects of Autoprobiotics on Serum and Urine Metabolomes in Patients With Metabolic Syndrome: A Pilot Study | |
| Zhang et al. | Supplemental Clostridium butyricumon modulates lipid metabolism of IUGR suckling piglets through reshaping the composition of gut microbiota and bile acid profile | |
| Fabersani Marrades et al. | Lactic Acid Bacteria Strains Differently Modulate Gut Microbiota and Metabolic and Immunological Parameters in High-Fat Diet-Fed Mice | |
| CA2998039C (en) | Use of pasteurized akkermansia for treating metabolic disorders | |
| Zheng et al. | Lactobacillus salivarius MZ27 enhances the host's resistance to DSS by modulating the gut microbiota and the AHR/GPX4 signaling pathway |